Suppr超能文献

鲍曼不动杆菌喹诺酮耐药临床分离株gyrA基因的突变

Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii.

作者信息

Vila J, Ruiz J, Goñi P, Marcos A, Jimenez de Anta T

机构信息

Departament de Microbiologia, Hospital Clinic, Facultat de Medicina, Universitat de Barcelona, Spain.

出版信息

Antimicrob Agents Chemother. 1995 May;39(5):1201-3. doi: 10.1128/AAC.39.5.1201.

Abstract

The gyrA gene mutations associated with quinolone resistance were determined in 21 epidemiologically unrelated clinical isolates of Acinetobacter baumannii. Our studies highlight the conserved sequences in the quinolone resistance-determining region of the gyrA gene from A. baumannii and other bacteria. All 15 isolates for which the MIC of ciprofloxacin is > or = 4 micrograms/ml showed a change at Ser-83 to Leu. Six strains for which the MIC of ciprofloxacin is 1 microgram/ml did not show any change at Ser-83, although a strain for which the MIC of ciprofloxacin is 1 microgram/ml exhibited a change at Gly-81 to Val. Although it is possible that mutations in other locations of the gyrA gene, the gyrB gene, or in other genes may also contribute to the modulation of the MIC level, our results suggest that a gyrA mutation at Ser-83 is associated with quinolone resistance in A. baumannii.

摘要

在21株流行病学上无关联的鲍曼不动杆菌临床分离株中测定了与喹诺酮耐药性相关的gyrA基因突变。我们的研究突出了鲍曼不动杆菌和其他细菌gyrA基因喹诺酮耐药决定区中的保守序列。环丙沙星MIC≥4微克/毫升的所有15株分离株在第83位丝氨酸处发生了向亮氨酸的改变。环丙沙星MIC为1微克/毫升的6株菌株在第83位丝氨酸处未显示任何改变,尽管环丙沙星MIC为1微克/毫升的1株菌株在第81位甘氨酸处发生了向缬氨酸的改变。虽然gyrA基因、gyrB基因或其他基因其他位置的突变也有可能导致MIC水平的调节,但我们的结果表明,第83位丝氨酸处的gyrA突变与鲍曼不动杆菌的喹诺酮耐药性相关。

相似文献

1
Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii.
Antimicrob Agents Chemother. 1995 May;39(5):1201-3. doi: 10.1128/AAC.39.5.1201.
3
Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii.
J Antimicrob Chemother. 1997 Jun;39(6):757-62. doi: 10.1093/jac/39.6.757.
4
Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
Microb Drug Resist. 2015 Jun;21(3):345-51. doi: 10.1089/mdr.2014.0057. Epub 2014 Dec 16.
8
Identification of distinct ciprofloxacin susceptibility in Acinetobacter spp. by detection of the gyrA gene mutation using real-time PCR.
Mol Cell Probes. 2009 Jun-Aug;23(3-4):154-6. doi: 10.1016/j.mcp.2009.02.004. Epub 2009 Mar 10.
9
Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.
J Antimicrob Chemother. 1999 Dec;44(6):743-8. doi: 10.1093/jac/44.6.743.
10
Resistance mechanism of Acinetobacter spp. strains resistant to DW-116, a new quinolone.
Arch Pharm Res. 1998 Jun;21(3):310-4. doi: 10.1007/BF02975293.

引用本文的文献

1
Exploring fluoroquinolone resistance mechanisms and the effects of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) in .
Front Med (Lausanne). 2025 May 9;12. doi: 10.3389/fmed.2025.1527662. eCollection 2025.
2
Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation.
JAC Antimicrob Resist. 2024 Aug 14;6(4):dlae127. doi: 10.1093/jacamr/dlae127. eCollection 2024 Aug.
7
Genetic Resistance Determinants in Clinical Genomes.
Antibiotics (Basel). 2022 May 17;11(5):676. doi: 10.3390/antibiotics11050676.

本文引用的文献

2
Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.
Antimicrob Agents Chemother. 1993 Jun;37(6):1247-52. doi: 10.1128/AAC.37.6.1247.
3
Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli.
Antimicrob Agents Chemother. 1993 Apr;37(4):696-701. doi: 10.1128/AAC.37.4.696.
5
Nosocomial acinetobacter meningitis secondary to invasive procedures: report of 25 cases and review.
Clin Infect Dis. 1993 Nov;17(5):843-9. doi: 10.1093/clinids/17.5.843.
6
Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings.
Clin Infect Dis. 1994 Jun;18(6):896-900. doi: 10.1093/clinids/18.6.896.
7
8
Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
Antimicrob Agents Chemother. 1994 Sep;38(9):2014-23. doi: 10.1128/AAC.38.9.2014.
10
Epidemiological markers of Acinetobacter baumannii clinical isolates from a spinal cord injury unit.
J Hosp Infect. 1994 Sep;28(1):39-48. doi: 10.1016/0195-6701(94)90151-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验